###begin article-title 0
Association of Interacting Genes in the Toll-Like Receptor Signaling Pathway and the Antibody Response to Pertussis Vaccination
###end article-title 0
###begin p 1
Conceived and designed the experiments: TK FS GK CT DSP. Performed the experiments: SB NR JR FS. Analyzed the data: TK GK CT DSP MK. Contributed reagents/materials/analysis tools: SB. Wrote the paper: TK MK.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 69 73 69 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 139 159 139 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bordetella pertussis</italic>
###xml 139 159 <span type="species:ncbi:520">Bordetella pertussis</span>
###xml 507 515 <span type="species:ncbi:9606">children</span>
Activation of the Toll-like receptor (TLR) signaling pathway through TLR4 may be important in the induction of protective immunity against Bordetella pertussis with TLR4-mediated activation of dendritic and B cells, induction of cytokine expression, and reversal of tolerance as crucial steps. We examined whether single nucleotide polymorphisms (SNPs) in genes of the TLR4 pathway and their interaction are associated with the response to whole-cell vaccine (WCV) pertussis vaccination in 490 one-year-old children.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 202 206 202 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD14</italic>
###xml 208 212 208 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 214 220 214 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TOLLIP</italic>
###xml 222 227 222 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TIRAP</italic>
###xml 229 234 229 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRAK3</italic>
###xml 236 241 236 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRAK4</italic>
###xml 243 249 243 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TICAM1</italic>
###xml 255 262 255 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFRSF4</italic>
###xml 386 392 386 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TOLLIP</italic>
###xml 525 526 525 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
We analyzed associations of 75 haplotype-tagging SNPs in genes in the TLR4 signaling pathway with pertussis toxin (PT)-IgG titers. We found significant associations between the PT-IgG titer and SNPs in CD14, TLR4, TOLLIP, TIRAP, IRAK3, IRAK4, TICAM1, and TNFRSF4 in one or more of the analyses. The strongest evidence for association was found for two SNPs (rs5744034 and rs5743894) in TOLLIP that were almost completely in linkage disequilibrium, provided statistically significant associations in all tests with the lowest p-values, and displayed a dominant mode of inheritance. However, none of these single gene associations would withstand correction for multiple testing. In addition, Multifactor Dimensionality Reduction Analysis, an approach that does not need correction for multiple testing, showed significant and strong two and three locus interactions between SNPs in TOLLIP (rs4963060), TLR4 (rs6478317) and IRAK1 (rs1059703).
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
We have identified significant interactions between genes in the TLR pathway in the induction of vaccine-induced immunity. These interactions underline that these genes are functionally related and together form a true biological relationship in a protein-protein interaction network. Practically all our findings may be explained by genetic variation in directly or indirectly interacting proteins at the extra- and intracytoplasmic sites of the cell membrane of antigen-presenting cells, B cells, or both. Fine tuning of interacting proteins in the TLR pathway appears important for the induction of an optimal vaccine response.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 69 89 69 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bordetella pertussis</italic>
###xml 331 343 331 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pertussis</italic>
###xml 404 407 404 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Girard1">[1]</xref>
###xml 409 412 409 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Mooi1">[2]</xref>
###xml 507 511 507 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 604 607 604 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Banus1">[3]</xref>
###xml 608 612 608 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Racke1">[10]</xref>
###xml 69 89 <span type="species:ncbi:520">Bordetella pertussis</span>
###xml 331 343 <span type="species:ncbi:520">B. pertussis</span>
###xml 547 551 <span type="species:ncbi:10090">mice</span>
###xml 590 594 <span type="species:ncbi:10090">mice</span>
###xml 599 602 <span type="species:ncbi:9606">men</span>
Whooping cough or pertussis is caused by the gram-negative bacterium Bordetella pertussis. Vaccination with both whole-cell (WCV) and acellular vaccine (ACV) limits the occurrence and severity of pertussis, but is unable to completely prevent infection and disease in vaccinated populations. Indeed, despite widespread vaccination B. pertussis remains endemic and has even re-emerged in many populations [1], [2]. Previous studies provided evidence for the role of the gene coding for Toll-like receptor 4 (TLR4) in both the infection process (in mice), and the response to vaccination (in mice and men) [3]-[10].
###end p 9
###begin p 10
###xml 199 203 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Medzhitov1">[11]</xref>
###xml 366 378 366 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pertussis</italic>
###xml 378 381 378 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Kerfoot1">[7]</xref>
###xml 383 386 383 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Poltorak1">[9]</xref>
###xml 388 392 388 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Racke1">[10]</xref>
###xml 533 537 533 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Kapsenberg1">[12]</xref>
###xml 851 854 840 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Banus1">[3]</xref>
###xml 856 859 845 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Mann1">[8]</xref>
###xml 30 35 <span type="species:ncbi:9606">human</span>
###xml 366 378 <span type="species:ncbi:520">B. pertussis</span>
###xml 551 555 <span type="species:ncbi:10090">mice</span>
TLR4 was the first identified human Toll-like receptor that belongs to a class of pathogen-associated molecular pattern receptors on antigen-presenting cells, such as macrophages and dendritic cells [11]. TLR4 is the receptor for bacterial lipopolysaccharide (LPS), and is also one of the receptors for pertussis toxin (PT), one of the dominant virulence factors of B. pertussis[7], [9], [10]. LPS recognition by TLR4 on dendritic cells induces a proinflammatory response, including IL-12 which supports the development of Th1 cells [12]. In infected mice we and others have established that functional TLR4 is required for an early interleukin (IL)-1beta, tumor necrosis factor (TNF)-alpha, and interferon (IFN)-gamma response that may enhance bacterial clearance, and thus, despite the proinflammatory nature of these cytokines, may limit pathology [3], [8].
###end p 10
###begin p 11
###xml 69 81 69 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pertussis</italic>
###xml 81 84 81 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Higgins1">[6]</xref>
###xml 86 90 86 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Banus4">[13]</xref>
###xml 260 272 260 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pertussis</italic>
###xml 272 275 272 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Higgins1">[6]</xref>
###xml 277 281 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Banus4">[13]</xref>
###xml 313 317 313 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tlr4</italic>
###xml 489 493 489 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tlr4</italic>
###xml 676 680 676 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 721 724 721 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Banus3">[5]</xref>
###xml 879 883 879 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Cherry1">[14]</xref>
###xml 884 888 884 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Taranger1">[16]</xref>
###xml 901 905 901 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Bruss1">[17]</xref>
###xml 69 81 <span type="species:ncbi:520">B. pertussis</span>
###xml 210 214 <span type="species:ncbi:10090">mice</span>
###xml 260 272 <span type="species:ncbi:520">B. pertussis</span>
###xml 328 332 <span type="species:ncbi:10090">mice</span>
###xml 504 508 <span type="species:ncbi:10090">mice</span>
###xml 712 720 <span type="species:ncbi:9606">children</span>
###xml 872 878 <span type="species:ncbi:9606">humans</span>
###xml 896 900 <span type="species:ncbi:10090">mice</span>
Signaling through TLR4 functions also in vaccine-induced immunity to B. pertussis[6], [13]. Whole cell pertussis vaccine (WCV), which contains abundant LPS, can induce the development of Th1- and Th17-cells in mice that mediate protective cellular immunity to B. pertussis[6], [13]. This response is abrogated in Tlr4-defective mice. In contrast, protection induced with acellular pertussis vaccine (ACV), which contains no or limited LPS, was compromised, but not completely abrogated in Tlr4-defective mice. In addition, we have observed that a lower PT-specific antibody response is associated with the minor allele of a single nucleotide polymorphism (SNP) (rs2770150) in TLR4 in one-year-old WCV-vaccinated children [5]. Unfortunately the functional significance of this SNP is still unknown. This antibody response correlates with protection against disease both in humans [14]-[16] and in mice [17].
###end p 11
###begin p 12
###xml 356 359 356 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tlr</italic>
###xml 381 393 381 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pertussis</italic>
###xml 509 521 509 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pertussis</italic>
###xml 532 535 532 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Banus2">[4]</xref>
###xml 381 393 <span type="species:ncbi:520">B. pertussis</span>
###xml 403 407 <span type="species:ncbi:10090">mice</span>
###xml 509 521 <span type="species:ncbi:520">B. pertussis</span>
TLR4 interacts with adaptor molecules, interacting proteins, effectors, downstream pathways and target genes, which together constitute the TLR signaling pathway. This pathway functions as a complex, mutually coherent system of functionally interacting molecules. Genes in such a pathway may be regulated together. Indeed, array expression analysis of the Tlr-signaling pathway in B. pertussis-infected mice revealed that 16 of the 47 genes within the Toll-like receptor signaling pathway were regulated upon B. pertussis infection [4]. Thus, the investigation of genetic associations and gene-gene interactions in this pathway may provide novel insights into the role of the TLR signaling pathway, and especially of protein-protein interactions in this pathway, in the host response to infection and vaccination.
###end p 12
###begin p 13
###xml 145 149 145 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Kimman1">[18]</xref>
###xml 459 463 459 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-VanDuin1">[19]</xref>
###xml 101 107 <span type="species:ncbi:9606">humans</span>
###xml 648 654 <span type="species:ncbi:9606">humans</span>
The role of the TLR signaling pathway, and genetic variation therein, in vaccine-induced immunity in humans has so far received little attention [18], although TLR-mediated activation of dendritic cells and B cells, induction of cytokine expression, and reversal of tolerance are crucial steps in the induction of immunity. Moreover, in addition to the microbial antigens in vaccines, several vaccine adjuvants have now clearly been identified as TLR ligands [19]. The current study therefore aims to provide further insight into the role of genes and gene-gene interactions in the TLR signaling pathway in the response to pertussis vaccination in humans.
###end p 13
###begin title 14
Materials and Methods
###end title 14
###begin title 15
Study cohort
###end title 15
###begin p 16
###xml 203 207 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Kummeling1">[20]</xref>
###xml 59 67 <span type="species:ncbi:9606">children</span>
###xml 209 221 <span type="species:ncbi:9606">Participants</span>
###xml 287 293 <span type="species:ncbi:9606">infant</span>
###xml 418 430 <span type="species:ncbi:9606">participants</span>
We collected capillary blood samples from 855 one-year-old children from the KOALA Birth Cohort Study, the Netherlands. The design and procedures of the KOALA cohort study have been described previously [20]. Participants were asked to give written informed consent to sampling of their infant's buccal swab as source of DNA, and capillary blood at the age of 1 year for the determination of serologic parameters. All participants had signed the informed consent. Ethical approval was obtained from the medical ethics committee of the Maastricht University/University Hospital of Maastricht. Genetic testing was included in the medical ethical committee and informed consent procedures.
###end p 16
###begin p 17
###xml 275 297 275 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Haemophilus influenzae</italic>
###xml 538 542 538 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-DeMelker1">[21]</xref>
###xml 4 12 <span type="species:ncbi:9606">children</span>
###xml 147 155 <span type="species:ncbi:9606">children</span>
###xml 275 297 <span type="species:ncbi:727">Haemophilus influenzae</span>
###xml 376 381 <span type="species:ncbi:9606">child</span>
###xml 414 422 <span type="species:ncbi:9606">children</span>
###xml 438 446 <span type="species:ncbi:9606">children</span>
###xml 564 572 <span type="species:ncbi:9606">children</span>
###xml 666 674 <span type="species:ncbi:9606">children</span>
###xml 779 787 <span type="species:ncbi:9606">children</span>
The children were vaccinated when they were 2, 3, 4, and 11 months old in the framework of the Dutch National Vaccination Program. We selected 704 children of which the parents indicated that they were vaccinated 4 times with WCV-containing diphteria-tetanus-pertussis-polio-Haemophilus influenzae type B vaccine. Parents were asked to collect buccal swabs for DNA from their child. We determined genotypes in 522 children. We excluded 5 children because their PT-IgG level was above 200 U/ml, which is indicative for a natural infection [21]. We also excluded 23 children because their mother, or both mother's parents were not born in the Netherlands. A further 4 children were excluded because less than 75% of their genotypes were available for analysis. Thus, data from 490 children were available for analysis.
###end p 17
###begin title 18
Antibody assay
###end title 18
###begin p 19
###xml 143 147 143 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-DeMelker1">[21]</xref>
The level of PT-specific immunoglobulin G (PT-IgG) was determined by enzyme-linked immunosorbent assay on capillary blood samples as described [21].
###end p 19
###begin title 20
SNP selection and genotyping
###end title 20
###begin p 21
###xml 249 255 240 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003665-g001">Fig. 1</xref>
###xml 547 551 538 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Mascart1">[22]</xref>
###xml 788 793 <span type="species:ncbi:9606">Human</span>
Based on the recent literature and assisted by the online pathway-visualization program Metacoretrade mark () we have made a selection of genes in the TLR signaling pathway that could be associated with pertussis vaccine-induced antibody responses (Fig. 1). Haplotype tagging SNPs were selected from the HapMap database () or from the Innate Immunity web site () depending on the largest number of SNPs with a minor allele frequency >0.1 available in each database. Because pertussis vaccines may modulate the balance between Th1 and Th2 immunity [22], we further screened the biomedical literature until October 2005 for SNPs within the candidate genes known to have functional impact on, or to be associated with Th2 diseases, notably asthma and atopy. SNPs were named according to the Human Genome Variation Society guidelines (). Rs numbers have been derived from the NCBI database ().
###end p 21
###begin title 22
Summary of the TLR pathway in antigen-presenting cells and the main results of this paper.
###end title 22
###begin p 23
###xml 705 709 705 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Kanehisa1">[50]</xref>
TLRs recognize molecular patterns associated with a broad range of pathogens including bacteria, fungi, protozoa and viruses. Vaccine components in WCV vaccine that may be recognized by TLR4 include LPS and PT. Following TLR4 activation, both the MyD88 and TICAM1 routes, leading to the expression of proinflammatory cytokines and type I IFNs respectively, may be activated. These promote the development of helper T cell responses providing T-cell help to B cells. TLR signaling in B cells may further promote the generation of antibody responses and the maintenance of serologic memory. TNFRSF4 is expressed on activated T cells. Adapted from BioCarta (), KEGG (Kyoto Encyclopedia of Genes and Genomes) [50], and Metacoretrade mark ().
###end p 23
###begin p 24
###xml 91 95 91 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Schrder1">[23]</xref>
###xml 413 417 395 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Bottema1">[24]</xref>
###xml 721 722 701 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 940 947 920 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003665-t001">Table 1</xref>
###xml 598 606 <span type="species:ncbi:9606">children</span>
###xml 852 860 <span type="species:ncbi:9606">children</span>
Genomic DNA was extracted from buccal swabs or blood by chloroform-2-propanolol extraction [23]. DNA was amplified by using REPLI-g UltraFast technology (Qiagentrade mark). Genotyping was performed by Competitive Allele-Specific PCR using KASPartrade mark genotyping chemistry, performed under contract by K-Biosciences (Cambridge, United Kingdom, ). Quality of genotype data was verified as described previously [24]. Briefly, we verified the genotyping quality by three steps: 1) a number of samples were genotyped in both genomic and amplified DNA; 2) inheritance of alleles between parents and children was checked using FBAT (); 3) genotype data were analyzed for deviations from Hardy-Weinberg equilibrium using chi2 statistics. Comparison of genotypes between genomic and amplified DNA and evaluation of inheritance patterns between parents and children revealed an excellent quality of the genotypes with a genotyping error of <1%. Table 1 summarizes the genes and number of SNPs analyzed.
###end p 24
###begin title 25
Genes and number of SNPs analyzed for association with vaccine-induced PT-specific immunoglobulin B response.
###end title 25
###begin p 26
###xml 53 58 <span type="species:ncbi:9606">Human</span>
Genes are named according to the nomenclature of the Human Genome Organisation (HUGO) ().
###end p 26
###begin p 27
SNP: single nucleotide polymorphism.
###end p 27
###begin title 28
Statistical analyses
###end title 28
###begin p 29
###xml 157 159 157 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 290 292 290 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 312 314 312 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 321 323 321 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 471 473 471 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 615 617 615 617 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 672 674 672 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 721 722 721 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 732 735 732 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Banus3">[5]</xref>
###xml 762 764 762 764 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 107 115 <span type="species:ncbi:9606">children</span>
###xml 240 248 <span type="species:ncbi:9606">children</span>
###xml 497 505 <span type="species:ncbi:9606">children</span>
###xml 790 798 <span type="species:ncbi:9606">children</span>
We used three parameters to examine genetic associations. First, we compared cases and controls defined as children with PT-IgG titers in the most extreme 10th percentiles. Secondly, we performed analyses with cases and controls defined as children with PT-IgG titers in the most extreme 33rd percentiles. The 10th and 33rd percentiles reflect the values of the PT-IgG titers below or above which 10 or 33 percent of the observations were found. The highest and lowest 10th percentiles (54 and 49 children respectively) were chosen because we previously found a SNP in TLR4 (rs2770150) associated with the lowest 10th percentile (low responders) compared to the highest 10th percentile (high responders) titer of PT-IgG (p = 0.027) [5]. The highest and lowest 33rd percentiles (154 and 166 children respectively) were chosen to obtain sufficient cases in the Multifactor Dimensionality Reduction (MDR) analyses. In addition we examined genetic association with PT-IgG titers in a continuous analysis, because IgG titers represent a continuous variable therewith circumventing arbitrary cut-off values.
###end p 29
###begin p 30
###xml 248 250 248 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 12 16 <span type="species:ncbi:9606">boys</span>
###xml 184 192 <span type="species:ncbi:9606">children</span>
Data from 4 boys were excluded in the MDR analyses since they had a heterozygous genotype for an IRAK1 SNP located on the X-chromosome. Thus for the MDR analyses data from 153 and 164 children were available with PT-IgG in the lowest and highest 33rd percentiles, respectively.
###end p 30
###begin p 31
###xml 115 116 115 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 376 377 376 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 279 285 <span type="species:ncbi:9606">infant</span>
After 10 based logarithmic transformation, the PT-IgG levels were normally distributed according to Levene's test (P>0.05). To examine possible confounding factors, we tested for associations between PT-IgG titer and the number of days between vaccination and blood sampling and infant gender using Pearson correlation. None of the factors tested influenced the PT-IgG level (P>0.05).
###end p 31
###begin p 32
###xml 181 182 181 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 200 205 200 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRAK4</italic>
###xml 218 224 218 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TOLLIP</italic>
###xml 242 246 242 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 273 279 273 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SIGIRR</italic>
###xml 431 436 431 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRAK1</italic>
###xml 493 497 <span type="species:ncbi:9606">boys</span>
We examined whether SNPs were in Hardy Weinberg equilibrium (HWE) using the chi-square test. As a result we excluded the following SNPs because they showed a significant deviation (p<0.001) from HWE: IRAK4 (rs146156), TOLLIP (rs5743854), and TLR4 (rs10759931). Two SNPs in SIGIRR were excluded because genotyping failed to give consistent results. Therewith 75 SNPs were available for analyses. As indicated above genotype data on IRAK1 SNPs (located on the X-chromosome) were excluded from 4 boys who had a heterozygous genotype.
###end p 32
###begin p 33
###xml 137 138 137 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 393 395 393 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 401 403 401 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 466 468 466 468 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 474 476 474 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 636 640 636 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Benjamini1">[25]</xref>
Univariate associations between genotypes and log PT-IgG titers were assessed by analysis of variance (ANOVA). When associations reached p-values<0.10, we further determined the best fitting genetic model (co-dominant, dominant, recessive or additive) in linear regression analysis. In addition we compared the distribution of alleles and genotypes among individuals with IgG in the highest 10th or 33rd percentiles with that of individuals with IgG in the lowest 10th or 33rd percentiles using Pearson's chi-square test. To control for multiple testing, we calculated the false discovery rate (FDR) according to Benjamini and Hochberg [25].
###end p 33
###begin p 34
###xml 150 154 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Ritchie1">[26]</xref>
###xml 954 956 954 956 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 1027 1029 1027 1029 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 1231 1232 1231 1232 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1399 1403 1399 1403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-VanBuuren1">[27]</xref>
###xml 2208 2209 2208 2209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 2551 2553 2551 2553 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 2673 2677 2673 2677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Moore1">[28]</xref>
Gene-gene interactions were studied using Multifactor Dimensionality Reduction (MDR version 1.0.0). MDR has been described in detail by Ritchie et al [26]. Briefly, this method reduces dimensionality of multifactor information to one dimension, i.e. high risk or low risk. First, the data are divided into a training set (9/10 of the data) and an independent testing set (1/10 of the data). The model with the best classification error is selected from the training set and the prediction error of that model is estimated using the testing set. This procedure is repeated 10 times, and the model with the combination of loci that maximizes the cross-validation consistency and minimizes the prediction error is selected. Cross-validation consistency is a measure of the number of times an MDR model is identified in each possible group of nine-tenths of the subjects. To obtain sufficient cases we performed MDR for individuals with IgG in the highest 33rd percentile defined as cases, and individuals with IgG in the lowest 33rd percentile as controls. For MDR we excluded 5 SNPs (rs2569190, rs5743894, rs5743859, rs5743987, and rs4986791) that were in strong linkage disequilibrium (LD) with other SNPs using a cut-off value of r2>0.80. LD was calculated using the software program Haploview. Because missing data are not allowed in MDR, missing SNPs were imputed using multiple imputation (MICE) [27]. MDR analyses were done separately using 5 imputation files, and subsequently average testing accuracies and cross-validation consistencies were calculated. The model with the highest average cross validation consistency and lowest average prediction error was selected as "best model". Average cross validation consistency is the number of times the model was selected as the best model after 10-fold cross-validation runs. Average testing balanced accuracy is the accuracy of classification of cases and controls in the testing dataset (one-tenth of the data) calculated as (Sensitivity+Specificity)/2. To examine the significance of testing accuracies, we determined 1,000 MDR analyses for each test after permutation (200 of each imputation file). The null-hypothesis was rejected when the one-sided p-value, as estimated by 1,000 permutations in Monte Carlo simulation, was <5%. In that case the "best model" predicts the status of cases and controls better than chance without the need to correct for multiple testing. Interactions revealed by MDR analysis were confirmed by linear regression (continuous data) and by logistic regression (33rd percentiles). Finally, interactions were visualized by constructing an interaction dendrogram according to Moore et al [28]. This dendrogram visualizes how much information about case-control status is gained by combining two or more SNPs using the MDR based on measures of entropy.
###end p 34
###begin title 35
Results
###end title 35
###begin title 36
Single gene associations
###end title 36
###begin p 37
###xml 95 102 95 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003665-t002">table 2</xref>
###xml 105 106 105 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 201 202 201 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 229 230 229 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 310 317 310 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003665-t003">Table 3</xref>
###xml 419 421 419 421 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 427 429 427 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 481 483 481 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 489 491 489 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 508 515 508 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003665-t004">table 4</xref>
###xml 680 683 680 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Banus3">[5]</xref>
###xml 734 736 734 736 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 1082 1089 1082 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003665-t003">table 3</xref>
###xml 1227 1229 1227 1229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 1236 1238 1236 1238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 1379 1381 1379 1381 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 1501 1502 1501 1502 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1592 1593 1592 1593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
In total 9 haplotype-tagging SNPs in 8 genes were significantly associated with PT-IgG levels (table 2). P-values were first calculated without prior assumption of the mode of inheritance (2 df). When p reached a value<0.10, the p-value belonging to the best fitting genetic model was subsequently calculated. Table 3 gives odds ratios (ORs) belonging to the best fitting genetic model for individuals in the highest 10th or 33rd percentile compared to individuals in the lowest 10th or 33rd percentile, and table 4 shows the PT-IgG titers of individuals with the indicated genotypes. The results confirmed the association of a SNP (rs2770150) in TLR4 as described by Banus et al [5], but only in the test that compares the extreme 10th percentiles. In addition we found associations between PT-IgG titer with SNPs in CD14, TOLLIP, TIRAP, IRAK3, IRAK4, TICAM1, and TNFRSF4. In the genetic models the ORs for SNPs that showed association in one or more tests was between 1.73 and 3.56 for alleles with a positive effect, and between 0.28 and 0.45 for alleles with a negative effect (table 3), indicating that individual genotypes appeared to have small to moderately strong main effects. The three tests (continuous analysis, 10th and 33rd percentiles) appeared to complement each other, with the least number of associations found in the tests comparing the highest and lowest 33rd percentiles. Two TOLLIP SNPs (rs5744034 and rs5743894) that were almost completely in linkage disequilibrium (D' = 1; r2 = 0.986), gave statistically significant associations in all three tests with the lowest p-values, and displayed a dominant mode of inheritance. None of the SNPs was significantly associated with the PT-IgG titer after controlling for multiple testing by FDR analysis.
###end p 37
###begin title 38
Single-nucleotide polymorphisms (SNPs) in genes from the TLR signaling pathway significantly associated with vaccine-induced PT-immunoglobulin G.
###end title 38
###begin p 39
###xml 0 61 0 61 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bold p-values become &lt;0.05 for the best fitting genetic model</bold>
Bold p-values become <0.05 for the best fitting genetic model.
###end p 39
###begin p 40
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 54 55 54 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
###xml 79 80 79 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 80 81 80 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
a Minor allele first; b MAF = minor allele frequency; c highest versus lowest; dP-values without prior assumption of the mode of inheritance (2 df).
###end p 40
###begin title 41
Odds ratios of significantly associated genotypes with vaccine-induced PT-immunoglobulin G.
###end title 41
###begin p 42
OR belonging to the best fitting genetic model.
###end p 42
###begin p 43
Confidence interval.
###end p 43
###begin p 44
On additive scale in a logistic regression model, i.e. multiplicative.
###end p 44
###begin title 45
Influence of single-nucleotide polymorphisms (SNPs) on vaccine-induced PT-immunoglobulin G titers.
###end title 45
###begin title 46
Gene-gene interactions
###end title 46
###begin p 47
###xml 70 76 70 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TOLLIP</italic>
###xml 90 94 90 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 128 133 128 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRAK1</italic>
###xml 174 176 174 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 225 227 225 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 257 264 257 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003665-t005">Table 5</xref>
###xml 266 273 266 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003665-g002">Fig. 2a</xref>
###xml 278 285 278 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003665-g002">Fig. 2b</xref>
MDR analyses revealed two significant genetic interactions of SNPs in TOLLIP (rs4963060), TLR4 (rs6478317; syn.: rs2737190) and IRAK1 (rs1059703) with cases in the highest 33rd percentile compared to controls in the lowest 33rd percentile of PT-IgG titers (Table 5, Fig. 2a and Fig. 2b).
###end p 47
###begin title 48
###xml 29 35 29 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TOLLIP</italic>
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRAK1</italic>
Genetic interactions between TOLLIP, TLR4, and IRAK1.
###end title 48
###begin p 49
###xml 242 244 242 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 345 347 345 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 407 413 407 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003665-g002">fig 2A</xref>
###xml 431 437 431 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003665-g002">fig 2B</xref>
###xml 530 532 530 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 656 658 656 658 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 204 212 <span type="species:ncbi:9606">children</span>
###xml 308 316 <span type="species:ncbi:9606">children</span>
Graphical display of evidence observed in MDR analysis of interaction among SNPs in TOLLIP (rs4963060), TLR4 (rs6478317) and IRAK1 (rs1059703). For each cell the left bar (empty) represents the number of children with PT-IgG in the highest 33rd percentile (total: 164) and the right bar (dark) the number of children with PT-IgG in the lowest 33rd percentile (total: 153) for the specific combination of 2 (fig 2A) or 3 genotypes (fig 2B). When the ratio is >164/153 the cell indicates a higher chance on a titer in the highest 33rd percentile (dark background), and when the ratio is <164/153 the cell indicates a higher chance on a titer in the lowest 33rd percentile (light background). 0, 1, and 2 represent the number of minor alleles.
###end p 49
###begin title 50
Results of gene-gene interactions analyzed by MDR.
###end title 50
###begin p 51
Average testing balanced accuracy is the accuracy of classification of cases and controls in the testing dataset (one-tenth of the data) calculated as (Sensitivity+Specificity)/2.
###end p 51
###begin p 52
Average cross validation consistency is the number of times the model was selected as the best model after 10-fold cross-validation runs.
###end p 52
###begin p 53
###xml 36 37 36 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Significance of accuracy (empirical p-value based on 1000 permutations).
###end p 53
###begin p 54
###xml 26 32 26 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TOLLIP</italic>
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 126 127 126 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 276 277 276 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 368 370 368 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 407 409 407 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 422 423 422 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 462 470 462 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003665-g002">Figure 2</xref>
###xml 775 777 775 777 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 790 797 790 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003665-g002">Fig. 2A</xref>
###xml 799 805 799 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003665-g003">Fig. 3</xref>
###xml 986 990 986 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Moore1">[28]</xref>
###xml 992 996 992 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Moore2">[29]</xref>
###xml 648 656 <span type="species:ncbi:9606">children</span>
First, a combination of a TOLLIP SNP (rs4963060) and a TLR4 SNP (rs6478317) had a strong synergistic effect on PT-IgG titers (p = 0.01; average testing balanced accuracy 61%). The interaction was confirmed by linear regression analysis for the level of PT-IgG as the outcome (p-value for interaction term = 0.01), and by logistic regression analysis for the highest 33rd percentile compared to the lowest 33rd percentile (p-value for interaction term = 0.0005). Figure 2 shows which combinations of genotypes have relatively high levels of PT-IgG, i.e. dark shaded cells with a high ratio of cases (left bars) and controls (right bars). Especially children with wild type genotypes of both TOLLIP (rs4963060) and TLR4 (rs6478317) had a high chance of PT-IgG in the highest 33rd percentile (Fig. 2A, Fig. 3). The strong and significant interaction between the TOLLIP (rs4963060) and TLR4 (rs6478317) SNPs was further indicated by a positive information gain based on measures of entropy [28], [29]. That is, information about case-control status is gained above that provided by the SNPs individually by combining the two SNPs (data not shown).
###end p 54
###begin title 55
###xml 13 19 13 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TOLLIP</italic>
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TRL4</italic>
Influence of TOLLIP and TRL4 and their interaction on log PT-IgG titers.
###end title 55
###begin p 56
###xml 13 19 13 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TOLLIP</italic>
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 452 453 452 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 463 464 463 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Influence of TOLLIP (rs4963060) and TLR4 (rs6478317) interaction on log PT-IgG titers following pertussis vaccination in a dominant model of inheritance. The presence of one or two minor alleles of one of these SNPs, but not the presence of one or two minor alleles of both SNPs, was associated with a lower PT-IgG titer. 0, 1, and 2 represent the number of minor alleles. * Significantly different from the group homozygous for the wild-type alleles (p = 0.04). P interaction term = 0.01. Vertical bars indicate standard errors.
###end p 56
###begin p 57
###xml 138 145 138 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003665-t005">table 5</xref>
###xml 223 224 223 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 243 250 243 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003665-g002">Fig. 2B</xref>
Second, an IRAK1 SNP (rs1059703) when added to the same combination (TOLLIP rs4963060 and TLR4 rs6478317) further increased the accuracy (table 5), and this combination was also significantly associated with PT-IgG titers (p = 0.01). However, Fig. 2B shows that most of the interactive effect must be attributed to TOLLIP and TLR4. Of note is that the SNPs showing genetic interaction were not associated with the vaccine responses in univariate analyses.
###end p 57
###begin title 58
Discussion
###end title 58
###begin p 59
###xml 108 120 108 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pertussis</italic>
###xml 632 644 632 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pertussis</italic>
###xml 957 960 957 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Banus1">[3]</xref>
###xml 962 965 962 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Banus3">[5]</xref>
###xml 967 970 967 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Higgins1">[6]</xref>
###xml 972 976 972 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Awomoyi1">[30]</xref>
###xml 978 982 978 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Tulic1">[31]</xref>
###xml 108 120 <span type="species:ncbi:520">B. pertussis</span>
###xml 457 465 <span type="species:ncbi:9606">children</span>
###xml 632 644 <span type="species:ncbi:520">B. pertussis</span>
###xml 929 956 <span type="species:ncbi:12814">respiratory syncytial virus</span>
Following earlier studies that provided evidence for the involvement of TLR4 in vaccine-induced immunity to B. pertussis, we elaborated on the role of genetic differences in other genes in the TLR signalling-pathway. This approach was based on the following. First, that TLR4 would likely function in a network of molecules, together forming a molecular pathway. Second, exploiting genetic differences in vaccine-induced responses in a cohort of vaccinated children would constitute a feasible approach to point to the functional role of genes that may be interesting to study in follow-up studies. Third, genes that play a role in B. pertussis vaccine-induced immunity may also be important in the response to other vaccines or the pathobiology of infection. Indeed, so far there is evidence that TLR4 affects both vaccine responses, as well as the course of infection with gram-negative bacteria and certain viruses, including respiratory syncytial virus [3], [5], [6], [30], [31].
###end p 59
###begin p 60
###xml 113 117 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD14</italic>
###xml 119 123 119 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 125 131 125 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TOLLIP</italic>
###xml 133 138 133 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TIRAP</italic>
###xml 140 145 140 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRAK3</italic>
###xml 147 152 147 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRAK4</italic>
###xml 154 160 154 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TICAM1</italic>
###xml 165 172 165 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNFRSF4</italic>
###xml 919 926 919 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003665-t006">Table 6</xref>
###xml 1201 1205 1201 1205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Kimman2">[32]</xref>
###xml 1402 1406 1402 1406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Dudbridge1">[33]</xref>
###xml 1407 1411 1407 1411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Sabatti1">[35]</xref>
###xml 2093 2105 2093 2105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B. pertussis</italic>
###xml 2214 2218 2203 2207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Banus4">[13]</xref>
###xml 2016 2024 <span type="species:ncbi:9606">children</span>
###xml 2058 2064 <span type="species:ncbi:10090">murine</span>
###xml 2093 2105 <span type="species:ncbi:520">B. pertussis</span>
This study indeed indicated association of haplotype-tagging SNPs in several genes in the TLR signaling pathway (CD14, TLR4, TOLLIP, TIRAP, IRAK3, IRAK4, TICAM1 and TNFRSF4) with the PT-specific antibody response following vaccination. This is an interesting observation that needs nevertheless to be interpreted with caution. Association between a gene polymorphism and a phenotype in a genetic-epidemiological study may, in isolation, convey little information about the causative role of the polymorphism. Besides identifying a real causative polymorphism directly responsible for the phenotype, allelic association may point to a polymorphism that is in close linkage disequilibrium to the associated marker. Indeed, as the haplotype-tagging SNPs are markers which capture most of the haplotypes in a region of linkage disequilibrium, and most associated SNPs have an unknown or no biologic function (summarized in Table 6), it is likely that the observed associations refer to genetic haplotype variation tagged by these SNPs. Such linkage disequilibrium, as well as gene-environment interactions, might vary between populations, and as a result association studies may yield conflicting results [32]. In addition, multiple testing in association studies may result in false discoveries, which necessitate the development of strategies to underline the evidence of gene involvement in a phenotype [33]-[35]. The single SNP associations found in this study did not withstand correction for multiple testing by FDR analysis (data not shown). Additional data are therefore needed to corroborate our findings. These may be derived by replication in other genetic-epidemiological studies, preferably in combination with studies on the functional role of gene products that provide biological plausibility. For example, it would be interesting to know whether individuals genetically different in TLR-pathway genes have altered proinflammatory cytokine production upon vaccination. These data are unavailable for the children from our cohort. However, in our murine model of wP vaccination and B. pertussis challenge, Tlr4 enhanced the production of the proinflammatory cytokines IL-1alpha, IL-1beta, and TNF-alpha [13].
###end p 60
###begin title 61
Summary of locations and functional data of SNPs in genes from the TLR signaling pathway significantly associated with vaccine-induced PT-immunoglobulin G.
###end title 61
###begin p 62
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
a Minor allele first; b associated in interaction.
###end p 62
###begin p 63
Data are based on the NCBI database () and the Innate Immunity web site ().
###end p 63
###begin p 64
###xml 103 107 103 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 109 115 109 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TOLLIP</italic>
###xml 121 126 121 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRAK1</italic>
The multiple testing problem does not apply to the strong genetic interaction we found between SNPs in TLR4, TOLLIP, and IRAK1. MDR chooses one best model from all possible combinations of attributes. Subsequently we tested the estimated accuracy of the best model for significance using the distribution of accuracies of best models under the null-hypothesis obtained after 1000 permutations. Therefore, the problem of multiple significance testing that inflates the type 1 error rate in single SNP analyses does not apply to MDR analyses. These genetic interactions therefore provide strong evidence that these genes are indeed involved in the response to vaccination and work together as functionally related genes in a single biological module.
###end p 64
###begin p 65
###xml 122 124 122 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 131 133 131 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rd</sup>
###xml 338 344 338 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TOLLIP</italic>
###xml 455 456 455 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 465 472 465 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003665-t002">Table 2</xref>
###xml 740 744 740 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Bulut1">[36]</xref>
###xml 746 750 746 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Zhang1">[37]</xref>
###xml 1068 1072 1063 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Didierlaurent1">[38]</xref>
###xml 804 808 <span type="species:ncbi:10090">mice</span>
We employed three different analyses, i.e. a continuous analysis and analyses comparing study subjects with the extreme 10th and 33rd percentiles in PT-IgG titer. Though not independent, these different analyses appeared to be complementary and confirmatory. The evidence of association was most consistent and strong for the SNPs in the TOLLIP gene, which showed association in all three analyses (at least at the genotype level) and also had the lowest p-values (Table 2). A role of TOLLIP in vaccine-induced immunity also appears plausible from its biological role and interactions in the TLR signaling pathway. TOLLIP is a small protein that binds the activated IL-1 receptor type I (IL-1RI) complex, as well as TLR2 and TLR4 complexes [36], [37]. TOLLIP also suppresses IRAK-1's kinase activity. In mice TOLLIP deficiency results in attenuated responses of the proinflammatory cytokines, IL-6, and TNF-alpha upon stimulation with IL-1ss and low doses of LPS. TOLLIP therefore likely acts in "fine tuning" or coordinating optimal signaling through IL-1RI and TLR4 [38]. We consider that physical interaction between TLR4, TOLLIP and IRAK1 or their concerted regulation may explain the genetic interaction of these genes. Although further work should proof that the SNPs (or SNPs in linkage disequilibrium) affect the physical interaction between these proteins, the agreement between physical and genetic interaction between functionally relevant genes within a single biological pathway is, to our knowledge, a unique finding.
###end p 65
###begin p 66
###xml 318 322 318 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Shin1">[39]</xref>
###xml 511 515 511 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD14</italic>
###xml 610 614 610 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD14</italic>
###xml 793 797 793 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Wiertsema1">[40]</xref>
###xml 580 588 <span type="species:ncbi:9606">children</span>
In addition to its interaction with TOLLIP, TLR4 together with CD14 and the myeloid differentiation protein-2 (MD-2), forms a pattern recognition receptor that plays an initiating role in the innate immune response to LPS from Gram-negative bacteria. The current view is that CD14 conveys LPS to the TLR4/MD-2 complex [39]. Evidently this cooperative function may explain the genetic association of CD14 with the WCV vaccine response found in this study. Previously genetic variation in another promoter SNP in CD14 has been shown to affect pneumococcal vaccine responsiveness in children. The T allele of the CD14 C-159T polymorphism (rs2569190) was associated with increased serum CD14 levels, and TT homozygotes showed higher serotype-specific anti-pneumococcal vaccine IgG antibody levels [40].
###end p 66
###begin p 67
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TIRAP</italic>
###xml 44 50 44 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TICAM1</italic>
###xml 413 417 413 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-West1">[41]</xref>
The associations of TIRAP SNP rs8177376 and TICAM1 SNP rs1046673 may also be explained by physical interaction or concerted regulation between TIRAP and TICAM1 with TOLLIP and TLR4. TIRAP and TICAM1 belong to the Toll/Interleukin-1 receptor (TIR) domain-containing adaptors, also including MyD88, that modulate TLR signaling pathways. TLRs thus can activate two distinct branches of downstream signaling pathways [41]. Our data suggest that both pathways are induced following WCV pertussis vaccination.
###end p 67
###begin p 68
###xml 324 328 324 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Kobayashi1">[42]</xref>
The interleukin-1 receptor-associated-kinases (IRAKs) are signal transduction mediators of the Toll and IL-1 receptor (IL-1R) families. IRAK3 and IRAK4 showed evidence for association in this study. These proteins may be involved in vaccine-induced immunity because they regulate TLR signaling and innate immune homeostasis [42].
###end p 68
###begin p 69
###xml 220 224 220 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Kobayashi1">[42]</xref>
###xml 226 230 226 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Humphreys1">[43]</xref>
###xml 385 389 385 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Hori1">[45]</xref>
###xml 403 407 403 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Munks1">[46]</xref>
###xml 693 697 693 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Munks1">[46]</xref>
###xml 699 703 699 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-BansalPakala1">[47]</xref>
###xml 417 421 <span type="species:ncbi:10090">mice</span>
Finally TNFRSF4 (syn. OX40 antigen, ACT35 antigen, CD134) showed evidence for association. TNFRSF4 is a cell surface antigen on T lymphocytes and a member of the tumor necrosis factor/nerve growth factor receptor family [42], [43]. Ligation of TNFRSF4 during T-cell-dendritic cell interaction is crucial for clonal expansion of antigen-specific T-cells and generation of T-cell memory [45]. Munks et al [46] found in mice that stimulation of TNFRSF4 increased the number of antigen-specific CD4 T cells following vaccination. Therefore it was suggested that stimulants of TNFRSF4 (and other members of its family) can improve the response to vaccination and may be useful as vaccine adjuvants [46], [47].
###end p 69
###begin p 70
###xml 328 334 328 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TOLLIP</italic>
###xml 336 340 336 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 346 351 346 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IRAK1</italic>
###xml 1159 1163 1155 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Pasare1">[48]</xref>
###xml 1266 1270 1262 1266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003665-Bernasconi1">[49]</xref>
Together, the majority of our findings point to the significance of directly or indirectly physically interacting proteins at the extra- and intracytoplasmic sites of the cell membrane of antigen presenting cells, or B cells, or both, in vaccine responsiveness. In particular we have identified significant interactions between TOLLIP, TLR4, and IRAK1. Further studies are required to explain how and where the genetic associations and interactions in the TLR pathway affect the PT antibody response. A T-dependent antibody response is clearly a multi-step process, and the TLR signalling pathway is likely involved in several of these steps. TLR signalling induces dendritic cell maturation and helper T cell activation, which are required to provide T-cell help to B cells. This may occur directly, or indirectly via cytokines, including IL-12 and TNF-alpha. In addition, activation of the TLR signaling pathway in B cells may be helpful or required for the generation of T-dependent antibody responses. This may occur by promoting antigen presentation by antigen-specific B cells and by promoting maturation of B cells into antibody-producing plasma cells [48]. In addition, TLR signaling in memory B cells may contribute to the maintenance of serological memory [49]. Altogether, we conclude that our combined data are a strong indication for the involvement of the TLR signaling pathway in the response to vaccination, as well as for the cooperation of its genes in a functional interacting network.
###end p 70
###begin title 71
References
###end title 71
###begin article-title 72
Which strategy for pertussis vaccination today?
###end article-title 72
###begin article-title 73
###xml 14 34 14 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bordetella pertussis</italic>
###xml 14 34 <span type="species:ncbi:520">Bordetella pertussis</span>
Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence?
###end article-title 73
###begin article-title 74
###xml 17 37 17 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bordetella pertussis</italic>
###xml 17 37 <span type="species:ncbi:520">Bordetella pertussis</span>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
Host genetics of Bordetella pertussis infection in mice: significance of Toll-like receptor 4 in genetic susceptibility and pathobiology.
###end article-title 74
###begin article-title 75
###xml 17 37 17 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bordetella pertussis</italic>
###xml 17 37 <span type="species:ncbi:520">Bordetella pertussis</span>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
Lung response to Bordetella pertussis infection in mice identified by gene-expression profiling.
###end article-title 75
###begin article-title 76
###xml 102 110 <span type="species:ncbi:9606">children</span>
Toll-like receptor 4 polymorphism associated with the response to whole-cell pertussis vaccination in children from the KOALA study.
###end article-title 76
###begin article-title 77
###xml 62 82 62 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bordetella pertussis</italic>
###xml 62 82 <span type="species:ncbi:520">Bordetella pertussis</span>
TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells.
###end article-title 77
###begin article-title 78
TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease.
###end article-title 78
###begin article-title 79
###xml 65 75 65 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bordetella</italic>
Comparative toll-like receptor 4-mediated innate host defense to Bordetella infection.
###end article-title 79
###begin article-title 80
###xml 52 56 <span type="species:ncbi:10090">mice</span>
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.
###end article-title 80
###begin article-title 81
PTX cruiser: driving autoimmunity via TLR4.
###end article-title 81
###begin article-title 82
Toll-like receptors and innate immunity.
###end article-title 82
###begin article-title 83
Dendritic-cell control of pathogen-driven T-cell polarization.
###end article-title 83
###begin article-title 84
The role of Toll-like receptor 4 in pertussis vaccine-induced immunity.
###end article-title 84
###begin article-title 85
###xml 49 69 49 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bordetella pertussis</italic>
###xml 49 69 <span type="species:ncbi:520">Bordetella pertussis</span>
A search for serologic correlates of immunity to Bordetella pertussis cough illnesses.
###end article-title 85
###begin article-title 86
###xml 86 106 86 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bordetella pertussis</italic>
###xml 86 106 <span type="species:ncbi:520">Bordetella pertussis</span>
Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis.
###end article-title 86
###begin article-title 87
Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis.
###end article-title 87
###begin article-title 88
Quantitative priming with inactivated pertussis toxoid vaccine in the aerosol challenge model.
###end article-title 88
###begin article-title 89
Genetic variation in the response to vaccination.
###end article-title 89
###begin article-title 90
Triggering TLR signaling in vaccination.
###end article-title 90
###begin article-title 91
Etiology of atopy in infancy: the KOALA Birth Cohort Study.
###end article-title 91
###begin article-title 92
###xml 155 175 155 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bordetella pertussis</italic>
###xml 155 175 <span type="species:ncbi:520">Bordetella pertussis</span>
Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis.
###end article-title 92
###begin article-title 93
###xml 18 24 <span type="species:ncbi:9606">infant</span>
Modulation of the infant immune responses by the first pertussis vaccine administrations.
###end article-title 93
###begin article-title 94
Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease.
###end article-title 94
###begin article-title 95
###xml 30 37 <span type="species:ncbi:4097">tobacco</span>
Interleukin 13, CD14, pet and tobacco smoke influence atopy in three Dutch cohorts: the allergenic study.
###end article-title 95
###begin article-title 96
Controlling the false discovery rate: a practical and powerful approach to multiple testing.
###end article-title 96
###begin article-title 97
Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity.
###end article-title 97
###begin article-title 98
###xml 36 40 <span type="species:ncbi:10090">mice</span>
Flexible multivariate imputation by mice.
###end article-title 98
###begin article-title 99
###xml 139 144 <span type="species:ncbi:9606">human</span>
A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility.
###end article-title 99
###begin article-title 100
###xml 50 55 <span type="species:ncbi:9606">human</span>
Bases, bits and disease: a mathematical theory of human genetics.
###end article-title 100
###begin article-title 101
###xml 51 78 <span type="species:ncbi:12814">respiratory syncytial virus</span>
###xml 102 109 <span type="species:ncbi:9606">infants</span>
###xml 120 128 <span type="species:ncbi:9606">children</span>
Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children.
###end article-title 101
###begin article-title 102
###xml 49 76 <span type="species:ncbi:12814">respiratory syncytial virus</span>
TLR4 polymorphisms mediate impaired responses to respiratory syncytial virus and lipopolysaccharide.
###end article-title 102
###begin article-title 103
Genetics of infectious disease susceptibility.
###end article-title 103
###begin article-title 104
Detecting multiple associations in genome-wide studies.
###end article-title 104
###begin article-title 105
###xml 24 29 <span type="species:ncbi:9606">human</span>
Advances in statistical human genetics over the last 25 years.
###end article-title 105
###begin article-title 106
Avoiding false discoveries in association studies.
###end article-title 106
###begin article-title 107
###xml 101 121 101 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Borrelia burgdorferi</italic>
###xml 101 121 <span type="species:ncbi:139">Borrelia burgdorferi</span>
Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling.
###end article-title 107
###begin article-title 108
Negative regulation of Toll-like receptor-mediated signaling by Tollip.
###end article-title 108
###begin article-title 109
Tollip regulates proinflammatory responses to interleukin-1 and lipopolysaccharide.
###end article-title 109
###begin article-title 110
Kinetics of binding of LPS to recombinant CD14, TLR4, and MD-2 proteins.
###end article-title 110
###begin article-title 111
Association of CD14 promoter polymorphism with otitis media and pneumococcal vaccine responses.
###end article-title 111
###begin article-title 112
Recognition and signaling by toll-like receptors.
###end article-title 112
###begin article-title 113
IRAK-M is a negative regulator of Toll-like receptor signaling.
###end article-title 113
###begin article-title 114
A critical role for OX40 in T cell-mediated immunopathology during lung viral infection.
###end article-title 114
###begin article-title 115
The costimulation-regulated duration of PKB activation controls T cell longevity.
###end article-title 115
###begin article-title 116
Roles of OX40 in the pathogenesis and the control of diseases.
###end article-title 116
###begin article-title 117
4-1BB and OX40 stimulation enhance CD8 and CD4 T-cell responses to a DNA prime, poxvirus boost vaccine.
###end article-title 117
###begin article-title 118
Signaling through OX40 (CD134) breaks peripheral T-cell tolerance.
###end article-title 118
###begin article-title 119
Control of B-cell responses by Toll-like receptors.
###end article-title 119
###begin article-title 120
###xml 62 67 <span type="species:ncbi:9606">human</span>
Maintenance of serological memory by polyclonal activation of human memory B cells.
###end article-title 120
###begin article-title 121
KEGG for linking genomes to life and the environment.
###end article-title 121
###begin p 122
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 122
###begin p 123
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was carried out as a cooperative project of the institutes of all authors. The institutes had no influence on the collection, analysis, and interpretation of the data, and on the preparation of the manuscript.
###end p 123

